The announcement comes just after Dexcom, another diabetes company, released its own consumer-friendly sensor. Here's what to ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Among the many corporations that pay a dividend, some do so unpredictably and irregularly. Others rarely raise their payouts ...

Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...

The FreeStyle Libre Glucose Monitoring System has a reader that can be used for life and is a one-time purchase. It is a three-in-one gadget that can test blood ketones, blood glucose, and continuous ...

Libre Flowers & Flames by YSL Beauty features a blend of coco-palm tree flower accord, lily flower, orange blossom and ...

While existing investors celebrate its outstanding stock performance, potential investors may wonder if they should buy it ...

Abbott (NYSE: ABT) today announced U.S. availability of Lingo™, the company's first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a ...

Roche will roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany. The company hopes to stand out from competitors with features to predict hypoglycemia.